理解腹部大手术限制性与开放性液体治疗试验结果:开放性液体是否与内皮损伤标志物升高相关?
该研究基于限制性与开放性液体治疗腹部大手术试验(NCT01424150)的单中心队列(161例),检测围术期内皮/糖萼损伤标志物。限制性组(n=75)与开放性组(n=86)之间所有标志物均无显著差异;按液体量低(n=81)与高(n=79)分组时,高液体组血浆血管生成素-2(p=0.009)和可溶性细胞间黏附分子-1(p=0.01)升高。作者认为结果与开放性液体后血管损伤的既往发现一致,但提示限制性与开放性液体治疗试验的临床结局可能由其他机制介导。
要点
- 限制性组(n=75)与开放性组(n=86)之间内皮/糖萼损伤标志物均无显著差异。
- 按液体量分组,高液体组(n=79)血浆血管生成素-2高于低液体组(n=81),p=0.009。
- 高液体组可溶性细胞间黏附分子-1高于低液体组,p=0.01。
- 其他标志物(血管生成素-1、可溶性酪氨酸蛋白激酶-2受体、多配体蛋白聚糖、肿瘤坏死因子-α)在高与低液体组间无差异。
- 作者认为这些结果提示限制性与开放性液体治疗试验的临床结局可能由其他机制介导。
适用人群与场景
- 接受腹部大手术的患者,来自限制性与开放性液体治疗腹部大手术试验的单中心队列(161例)。
研究设计与关键结果
- 研究类型:国际、随机、评估者盲法试验的限制性与开放性液体治疗腹部大手术试验的队列分析,血液标本来自单一主要中心(161例),于术前、术后第1天和第3天采集。
- 干预与对照:限制性与开放性静脉液体方案,代表腹部大手术患者的传统治疗;血液标本盲法随机分批检测内皮/糖萼损伤血浆标志物。
- 主要结果:限制性组(n=75)与开放性组(n=86)之间任何标志物均无显著差异。
- 按液体量分组:高液体组(n=79)血浆血管生成素-2高于低液体组(n=81),p=0.009;可溶性细胞间黏附分子-1高于低液体组,p=0.01。
- 其他标志物在高与低液体组间无差异。
证据类型、等级与局限
- 证据类型:随机对照试验的队列生物标志物分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,虽然结果与开放性液体治疗后血管损伤的既往发现一致,但限制性与开放性液体治疗腹部大手术试验的临床结局可能由其他机制介导。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
UNLABELLED: Liberal fluid strategies in critically ill patients are associated with harm, thought to be due to endothelial and glycocalyx injury. As the restrictive versus liberal fluid therapy for major abdominal surgery trial not only failed to report survival benefit with restrictive fluids but was associated with a higher rate of acute kidney injury, we hypothesized that factors other than endothelial and glycocalyx injury were likely to account for these findings. Consequently, we measured injury biomarkers in a cohort of the restrictive versus liberal fluid therapy for major abdominal surgery trial.
DESIGN: The restrictive versus liberal fluid therapy for major abdominal surgery trial was an international, randomized, assessor-blinded trial comparing restrictive with liberal IV fluid regimens that represented traditional care in patients undergoing major abdominal surgery.
SETTING AND PATIENTS: Cohort of restrictive versus liberal fluid therapy for major abdominal surgery bloods was collected at a single major site (161 patients) prior to, day 1 and day 3 after surgery.
INTERVENTION: Bloods were blindly and randomly batch analyzed for plasma markers of endothelial/glycocalyx injury-angiopoietin-1, angiopoietin-2, soluble tyrosine-protein kinase-2 receptor, soluble intracellular adhesion molecule-1, syndecan, and tumor necrosis factor-α. Data were examined as restrictive versus liberal enrollment groups and high versus low (± 5,000 mL) fluid groups. Differences were examined by linear mixed modeling.
MEASUREMENT AND MAIN RESULTS: There were no significant differences in any biomarkers between the restrictive (n = 75) and liberal (n = 86) groups. When examined as low (n = 81) and high (n = 79) fluid groups, plasma angiopoietin-2 (p = 0.009) and soluble intracellular adhesion molecule-1 (p = 0.01) were elevated in the high fluid group. There were no differences in other biomarkers.
CONCLUSIONS: Although these results are consistent with previous findings of vascular injury following liberal fluid therapy, they suggest alternative mechanisms underlie the clinical outcomes from restrictive versus liberal fluid therapy for major abdominal surgery study.
CLINICALTRIALSGOV IDENTIFIER: NCT01424150.
参考来源
- Bihari S, Dixon DL, Painter T, et al. Understanding Restrictive Versus Liberal Fluid Therapy for Major Abdominal Surgery Trial Results: Did Liberal Fluids Associate With Increased Endothelial Injury Markers? Crit Care Explor. 2021. PMID: 33521643. doi:10.1097/CCE.0000000000000316
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。